Study of BHV-1300 in Graves' Disease
NCT06980649
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Graves Disease
Interventions
DRUG:
BHV-1300
Sponsor
Biohaven Therapeutics Ltd.